...
Intervention #2 Plan | Intervention #2 Actual |
Describe Intervention Chosen intervention: Statin tool implementation (Statin and lifestyle inforgraphicinfographic) Plan for intervention: Outreach to patients who are identified as high-risk and not currently taking any form of statin therapy. Include pop health outreach process to send letter and tool to patients in advance of their visits. | Chosen Intervention: Date when implemented: Updates: waiting for Spanish translation (has been sourced as of 11/27) student pharmacist outreaching to eligible patients . Cohort of patients comp chart review looking for contraindications liver, active hepatitis, why statin therapy appropriate based on ascvd risk, sending to pcp to invite to come back into care - pcp or student pharmacist schedule, also mailing out statin education - have review 227 charts so far, of those 36 who were due for statin therapy and no contraindications and no reason why not prescribed, another 25 with a caveat in the charts. next step will be to look at patient records in subpopulation who had an appointment and those were started on statin therapy. Some of other patients were already on therapy or flatly declined/want to do lifestyle first. Smaller population of people who are not still engaged in care |
Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention) | |
Reach of implementers/providers? Planned: Planned 50-60 providers across 3 sites | Reach of implementers/providers? Actual: 2/5 have focused most of efforts in this intervention - support of student pharmacists. high risk ascvd comorbid htn. chart review of 228 eligible patients and sent out letters and scheduling visits identified that many patients who weren’t sure were on statins but actually are. 20% had already initiated, main reason for other 80% difficulty to contact pt and those reached. 227 evaluated, 77 on statin, 96 needs to start - 77 of these had not yet initiated and there were 39 unable to reach, 12 PCP had emphasized lifestyle modifications instead of statin initiation (haven’t followed up on this yet), 2 risk outweighed benefit deeper dive of those needed to start statin - sent FAQ to eligible patients (NACHC document) of those scheduled who came in (need to evaluate this) |
Reach of patients? Planned: patients with diabetes (roughly 200-300 patients – roughly 150 would get the letter intervention pre-visit) | Reach of patients? Actual: |
Efficacy (Impact of intervention on important outcomes) | |
How will you measure that your intervention is working? Step 1: Proportion of patients who received the pre-visit letter and initiated a statin AND came in for a visit. Step 2: Received a statin after the visit. | Were you able to accurately measure how your intervention was working? |
What outcomes do you expect? | What outcomes have you seen? |
How will you ensure your intervention will be effective for your target population? | Did your intervention reach the target population? |
What unintended consequences or outcomes might there be? Challenge – tracking list of patients who were sent/received a statin tool letter. Linking this pop health activity to the EMR would streamline the mailing and tracking process. Report pulls will need to be regular to determine if the intervention is working. | What unintended outcomes did you experience? |
Adoption (#/% and representativeness of staff and sites who implemented the intervention) How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia? | |
Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable. . QI Team | Who delivered the intervention? Did they have the skills and time needed to complete the intervention? |
How will you know if clinicians/care teams/sites used the intervention? | What proportion of the planned staff/sites implemented the intervention? Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)? |
Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention) | |
How will you know what adaptations or modifications were made during the intervention? | How did you track modifications during the intervention? |
What might be some of the possible obstacles to consistent implementation? | What were the barriers to consistent intervention implementation? |
What costs and resources (including time and burden, not just money) need to be considered? | What costs and resources (including time and burden, not just money) need to be considered? |
How closely did the staff/sites follow the intervention design and deliver as intended? Check all that apply:
Modifications made and other notes: | |
Maintenance (Extent to which intervention is part of routine practices and protocols) | |
What reinforcements will you put in place to sustain the intervention, if effective?
Explain: | What reinforcements did you put into place to sustain the intervention?
Explain: |
How will you spread your intervention and lessons learned? HC training and Aliados Health Peer meetings | How will you spread your intervention and lessons learned? |
What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)? | |
...